FDA Guidance Will Advance Use of Real-World Evidence, Gottlieb Says

Drug Industry Daily
To help relieve uncertainty among sponsors about its role in regulatory decisions, the FDA will publish guidance on its application of real-world evidence to drug approvals and post-market evaluations, FDA Commissioner Scott Gottlieb told the National Academy of Sciences.

To View This Article:


Subscribe To Drug Industry Daily